EMEA (Europe, Middle East and Africa) Non-alcoholic Steatohepatitis Market Report 2018

March 2018 | 116 pages | ID: E247DF37AC6QEN
QYResearch

Abstracts

In this report, the EMEA Non-alcoholic Steatohepatitis market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Non-alcoholic Steatohepatitis for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Non-alcoholic Steatohepatitis market competition by top manufacturers/players, with Non-alcoholic Steatohepatitis sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Arena Pharmaceuticals
• GSK
• Novo Nordisk
• Roche
• Vivus
• Arisaph Pharmaceuticals
• Cempra Pharmaceuticals
• Galectin Therapeutics
• Galmed Pharmaceuticals
• Genfit
• Gilead
• Immuron
• Interceptpharma
• Raptor Pharmaceutical
• Shire
• Tobira Therapeutics
• Verva
• Viking Therapeutics

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Solid
• Liquid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oral
• Parenteral

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Non-alcoholic Steatohepatitis Market Report 2018

1 NON-ALCOHOLIC STEATOHEPATITIS OVERVIEW

1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis
1.2 Classification of Non-alcoholic Steatohepatitis
  1.2.1 EMEA Non-alcoholic Steatohepatitis Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Non-alcoholic Steatohepatitis Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Solid
  1.2.4 Liquid
1.3 EMEA Non-alcoholic Steatohepatitis Market by Application/End Users
  1.3.1 EMEA Non-alcoholic Steatohepatitis Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Oral
  1.3.3 Parenteral
1.4 EMEA Non-alcoholic Steatohepatitis Market by Region
  1.4.1 EMEA Non-alcoholic Steatohepatitis Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Non-alcoholic Steatohepatitis (2013-2025)
  1.5.1 EMEA Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2025)

2 EMEA NON-ALCOHOLIC STEATOHEPATITIS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Non-alcoholic Steatohepatitis Market Competition by Players/Manufacturers
  2.1.1 EMEA Non-alcoholic Steatohepatitis Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Non-alcoholic Steatohepatitis Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Non-alcoholic Steatohepatitis Sale Price by Players (2013-2018)
2.2 EMEA Non-alcoholic Steatohepatitis (Volume and Value) by Type/Product Category
  2.2.1 EMEA Non-alcoholic Steatohepatitis Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Non-alcoholic Steatohepatitis Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Non-alcoholic Steatohepatitis Sale Price by Type (2013-2018)
2.3 EMEA Non-alcoholic Steatohepatitis (Volume) by Application
2.4 EMEA Non-alcoholic Steatohepatitis (Volume and Value) by Region
  2.4.1 EMEA Non-alcoholic Steatohepatitis Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Non-alcoholic Steatohepatitis Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Non-alcoholic Steatohepatitis Sales Price by Region (2013-2018)

3 EUROPE NON-ALCOHOLIC STEATOHEPATITIS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Non-alcoholic Steatohepatitis Sales and Value (2013-2018)
  3.1.1 Europe Non-alcoholic Steatohepatitis Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)
3.2 Europe Non-alcoholic Steatohepatitis Sales and Market Share by Type
3.3 Europe Non-alcoholic Steatohepatitis Sales and Market Share by Application
3.4 Europe Non-alcoholic Steatohepatitis Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Non-alcoholic Steatohepatitis Sales Volume by Countries (2013-2018)
  3.4.2 Europe Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)
  3.4.3 Germany Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  3.4.4 France Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  3.4.5 UK Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  3.4.6 Russia Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  3.4.7 Italy Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)

4 MIDDLE EAST NON-ALCOHOLIC STEATOHEPATITIS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Non-alcoholic Steatohepatitis Sales and Value (2013-2018)
  4.1.1 Middle East Non-alcoholic Steatohepatitis Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)
4.2 Middle East Non-alcoholic Steatohepatitis Sales and Market Share by Type
4.3 Middle East Non-alcoholic Steatohepatitis Sales and Market Share by Application
4.4 Middle East Non-alcoholic Steatohepatitis Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Non-alcoholic Steatohepatitis Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  4.4.4 Israel Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  4.4.5 UAE Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  4.4.6 Iran Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)

5 AFRICA NON-ALCOHOLIC STEATOHEPATITIS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Non-alcoholic Steatohepatitis Sales and Value (2013-2018)
  5.1.1 Africa Non-alcoholic Steatohepatitis Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)
5.2 Africa Non-alcoholic Steatohepatitis Sales and Market Share by Type
5.3 Africa Non-alcoholic Steatohepatitis Sales and Market Share by Application
5.4 Africa Non-alcoholic Steatohepatitis Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Non-alcoholic Steatohepatitis Sales Volume by Countries (2013-2018)
  5.4.2 Africa Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)
  5.4.3 South Africa Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Non-alcoholic Steatohepatitis Sales and Growth Rate (2013-2018)

6 EMEA NON-ALCOHOLIC STEATOHEPATITIS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Arena Pharmaceuticals
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Novo Nordisk
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Roche
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Roche Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Vivus
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Vivus Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Arisaph Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Cempra Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Galectin Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Galmed Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Non-alcoholic Steatohepatitis Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Genfit
6.12 Gilead
6.13 Immuron
6.14 Interceptpharma
6.15 Raptor Pharmaceutical
6.16 Shire
6.17 Tobira Therapeutics
6.18 Verva
6.19 Viking Therapeutics

7 NON-ALCOHOLIC STEATOHEPATITIS MANUFACTURING COST ANALYSIS

7.1 Non-alcoholic Steatohepatitis Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Non-alcoholic Steatohepatitis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-alcoholic Steatohepatitis Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NON-ALCOHOLIC STEATOHEPATITIS MARKET FORECAST (2018-2025)

11.1 EMEA Non-alcoholic Steatohepatitis Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Non-alcoholic Steatohepatitis Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Non-alcoholic Steatohepatitis Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Non-alcoholic Steatohepatitis Price and Trend Forecast (2018-2025)
11.2 EMEA Non-alcoholic Steatohepatitis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Non-alcoholic Steatohepatitis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Non-alcoholic Steatohepatitis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Non-alcoholic Steatohepatitis Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Non-alcoholic Steatohepatitis Sales Forecast by Type (2018-2025)
11.7 EMEA Non-alcoholic Steatohepatitis Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Non-alcoholic Steatohepatitis
Figure EMEA Non-alcoholic Steatohepatitis Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Non-alcoholic Steatohepatitis Sales Volume Market Share by Type (Product Category) in 2017
Figure Solid Product Picture
Figure Liquid Product Picture
Figure EMEA Non-alcoholic Steatohepatitis Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Non-alcoholic Steatohepatitis by Application in 2017
Figure Oral Examples
Table Key Downstream Customer in Oral
Figure Parenteral Examples
Table Key Downstream Customer in Parenteral
Figure EMEA Non-alcoholic Steatohepatitis Market Size (Million USD) by Region (2013-2025)
Figure Europe Non-alcoholic Steatohepatitis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Non-alcoholic Steatohepatitis Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Non-alcoholic Steatohepatitis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Non-alcoholic Steatohepatitis Revenue (Million USD) Status and Forecast by Countries
Figure Africa Non-alcoholic Steatohepatitis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Non-alcoholic Steatohepatitis Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Non-alcoholic Steatohepatitis Sales Volume and Growth Rate (2013-2025)
Figure EMEA Non-alcoholic Steatohepatitis Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Non-alcoholic Steatohepatitis Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales Share by Players (2013-2018)
Figure 2017 Non-alcoholic Steatohepatitis Sales Share by Players
Figure 2017 Non-alcoholic Steatohepatitis Sales Share by Players
Figure EMEA Non-alcoholic Steatohepatitis Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Revenue (Million USD) by Players (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Revenue Share by Players (2013-2018)
Table 2017 EMEA Non-alcoholic Steatohepatitis Revenue Share by Players
Table 2017 EMEA Non-alcoholic Steatohepatitis Revenue Share by Players
Table EMEA Non-alcoholic Steatohepatitis Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales Share by Type (2013-2018)
Figure Sales Market Share of Non-alcoholic Steatohepatitis by Type (2013-2018)
Figure EMEA Non-alcoholic Steatohepatitis Sales Market Share by Type (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Non-alcoholic Steatohepatitis by Type in 2017
Table EMEA Non-alcoholic Steatohepatitis Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales Share by Application (2013-2018)
Figure Sales Market Share of Non-alcoholic Steatohepatitis by Application (2013-2018)
Figure EMEA Non-alcoholic Steatohepatitis Sales Market Share by Application in 2017
Table EMEA Non-alcoholic Steatohepatitis Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Sales Share by Region (2013-2018)
Figure Sales Market Share of Non-alcoholic Steatohepatitis by Region (2013-2018)
Figure EMEA Non-alcoholic Steatohepatitis Sales Market Share in 2017
Table EMEA Non-alcoholic Steatohepatitis Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Non-alcoholic Steatohepatitis Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Non-alcoholic Steatohepatitis by Region (2013-2018)
Figure EMEA Non-alcoholic Steatohepatitis Revenue Market Share Regions in 2017
Table EMEA Non-alcoholic Steatohepatitis Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)
Table Europe Non-alcoholic Steatohepatitis Sales (K Units) by Type (2013-2018)
Table Europe Non-alcoholic Steatohepatitis Market Share by Type (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Market Share by Type in 2017
Table Europe Non-alcoholic Steatohepatitis Sales (K Units) by Application (2013-2018)
Table Europe Non-alcoholic Steatohepatitis Market Share by Application (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Market Share by Application in 2017
Table Europe Non-alcoholic Steatohepatitis Sales (K Units) by Countries (2013-2018)
Table Europe Non-alcoholic Steatohepatitis Sales Market Share by Countries (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Sales Market Share by Countries (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Sales Market Share by Countries in 2017
Table Europe Non-alcoholic Steatohepatitis Revenue (Million USD) by Countries (2013-2018)
Table Europe Non-alcoholic Steatohepatitis Revenue Market Share by Countries (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Revenue Market Share by Countries (2013-2018)
Figure Europe Non-alcoholic Steatohepatitis Revenue Market Share by Countries in 2017
Figure Germany Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure France Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure UK Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Non-alcoholic Steatohepatitis Sales (K Units) by Type (2013-2018)
Table Middle East Non-alcoholic Steatohepatitis Market Share by Type (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Market Share by Type (2013-2018)
Table Middle East Non-alcoholic Steatohepatitis Sales (K Units) by Applications (2013-2018)
Table Middle East Non-alcoholic Steatohepatitis Market Share by Applications (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Sales Market Share by Application in 2017
Table Middle East Non-alcoholic Steatohepatitis Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Non-alcoholic Steatohepatitis Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Sales Volume Market Share by Countries in 2017
Table Middle East Non-alcoholic Steatohepatitis Revenue (Million USD) by Countries (2013-2018)
Table Middle East Non-alcoholic Steatohepatitis Revenue Market Share by Countries (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Revenue Market Share by Countries (2013-2018)
Figure Middle East Non-alcoholic Steatohepatitis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Non-alcoholic Steatohepatitis Sales (K Units) by Type (2013-2018)
Table Africa Non-alcoholic Steatohepatitis Sales Market Share by Type (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Sales Market Share by Type (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Sales Market Share by Type in 2017
Table Africa Non-alcoholic Steatohepatitis Sales (K Units) by Application (2013-2018)
Table Africa Non-alcoholic Steatohepatitis Sales Market Share by Application (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Sales Market Share by Application (2013-2018)
Table Africa Non-alcoholic Steatohepatitis Sales Volume (K Units) by Countries (2013-2018)
Table Africa Non-alcoholic Steatohepatitis Sales Market Share by Countries (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Sales Market Share by Countries (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Sales Market Share by Countries in 2017
Table Africa Non-alcoholic Steatohepatitis Revenue (Million USD) by Countries (2013-2018)
Table Africa Non-alcoholic Steatohepatitis Revenue Market Share by Countries (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Revenue Market Share by Countries (2013-2018)
Figure Africa Non-alcoholic Steatohepatitis Revenue Market Share by Countries in 2017
Figure South Africa Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Table AstraZeneca Non-alcoholic Steatohepatitis Basic Information List
Table AstraZeneca Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure AstraZeneca Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Arena Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information List
Table Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Arena Pharmaceuticals Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table GSK Non-alcoholic Steatohepatitis Basic Information List
Table GSK Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure GSK Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure GSK Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Novo Nordisk Non-alcoholic Steatohepatitis Basic Information List
Table Novo Nordisk Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Novo Nordisk Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Novo Nordisk Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Roche Non-alcoholic Steatohepatitis Basic Information List
Table Roche Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Roche Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Roche Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Vivus Non-alcoholic Steatohepatitis Basic Information List
Table Vivus Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Vivus Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Vivus Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Vivus Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information List
Table Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information List
Table Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Galectin Therapeutics Non-alcoholic Steatohepatitis Basic Information List
Table Galectin Therapeutics Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Galectin Therapeutics Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Galectin Therapeutics Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Galectin Therapeutics Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Basic Information List
Table Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2013-2018)
Figure Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales Market Share in EMEA (2013-2018)
Figure Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Revenue Market Share in EMEA (2013-2018)
Table Genfit Non-alcoholic Steatohepatitis Basic Information List
Table Gilead Non-alcoholic Steatohepatitis Basic Information List
Table Immuron Non-alcoholic Steatohepatitis Basic Information List
Table Interceptpharma Non-alcoholic Steatohepatitis Basic Information List
Table Raptor Pharmaceutical Non-alcoholic Steatohepatitis Basic Information List
Table Shire Non-alcoholic Steatohepatitis Basic Information List
Table Tobira Therapeutics Non-alcoholic Steatohepatitis Basic Information List
Table Verva Non-alcoholic Steatohepatitis Basic Information List
Table Viking Therapeutics Non-alcoholic Steatohepatitis Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Steatohepatitis
Figure Manufacturing Process Analysis of Non-alcoholic Steatohepatitis
Figure Non-alcoholic Steatohepatitis Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Steatohepatitis Major Manufacturers in 2017
Table Major Buyers of Non-alcoholic Steatohepatitis
Table Distributors/Traders List
Figure EMEA Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Non-alcoholic Steatohepatitis Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Non-alcoholic Steatohepatitis Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Non-alcoholic Steatohepatitis Sales Market Share Forecast by Region (2018-2025)
Table EMEA Non-alcoholic Steatohepatitis Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Non-alcoholic Steatohepatitis Revenue Market Share Forecast by Region (2018-2025)
Table Europe Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Non-alcoholic Steatohepatitis Sales Market Share Forecast by Countries (2018-2025)
Table Europe Non-alcoholic Steatohepatitis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Non-alcoholic Steatohepatitis Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Non-alcoholic Steatohepatitis Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Non-alcoholic Steatohepatitis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Non-alcoholic Steatohepatitis Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Non-alcoholic Steatohepatitis Sales Market Share Forecast by Countries (2018-2025)
Table Africa Non-alcoholic Steatohepatitis Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Non-alcoholic Steatohepatitis Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Non-alcoholic Steatohepatitis Sales Market Share Forecast by Type (2018-2025)
Table EMEA Non-alcoholic Steatohepatitis Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Non-alcoholic Steatohepatitis Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources